PFE Directional Report
Analysis based on market close March 31, 2026
Outlook
Bullish with a pinning bias toward $27-$28. Confidence: 7/10. Strong positive GEX ($222.9M) and bullish flow (P/C vol 0.40) support upside, but spot is 6% above the nearest max pain, creating a short-term gravitational pull lower.
Conflicts: Spot ($28.08) is above nearest max pain ($26.50 for 3/27), suggesting a potential drift lower to meet pinning gravity.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+222.9M
DEX: +70.2M shares
Gamma flip: ~$20 (Approx โ based on put OI concentration of 60,221)
NTM gamma: Dealers are **net long $222.9M gamma**, strongest near $27-$28 strikes. A move **+2% to ~$28.65** increases pinning pressure. A move **-2% to ~$27.50** likely sees accelerated dealer buying (long gamma), providing a cushion.
IV Analysis
IV vs VIX: IV 29.0% โ No VIX provided for direct comparison, but term structure shows no extreme richness or cheapness.
Term structure: **Humped with a kink at 5/08 (38 DTE, IV 33.2%).** This is likely pricing the 5/05 earnings event. IV drops sharply after (29.1% for 5/15).
Skew: **~7 vol-point differential between 5/08 (33.2%) and 5/15 (29.1%)** โ supports a post-earnings vol crush calendar spread (sell May 8, buy May 15).
Flow Analysis
Net premium: +$6.3M bullish; P/C vol 0.40 (extreme call skew), P/C OI 0.82.
Directional prints: $28C saw $1.54M net premium (Vol 3.6k vs OI 45k) โ likely **bought calls** for upside. $30.50C 4/17 saw 966 vol vs 203 OI (4.8x) at low IV (23.6%) โ could be bullish speculation or a covered call roll. Interpretation: Bullish flow is more consistent with the regime.
Unusual: $29P 5/15 saw 463 vol vs 290 OI (1.6x) at elevated IV (30.9%) โ could be a protective put buy or premium sale. Given high IV and earnings proximity, selling is more likely.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long Stock | Moderate-Strong | Buy shares at market (~$28.08). | Pullback to max pain ($26.50); sector/macro downturn. |
| Short Stock | Weak | N/A | Contravenes strong bullish flow and positive GEX; only viable on a break below $25. |
| Covered Call | Moderate-Strong | Own shares, sell $30C 5/15 (45 DTE) for ~$0.45. | Shares rally past $30, capping upside. |
| Cash-Secured Put / Put Spread | Moderate-Strong | Sell $27/$26 put spread 4/17 (17 DTE) for ~$0.30 credit. | Spot breaks below $27 support. |
| Long Calls | Moderate | Buy $28C 5/15 (45 DTE) for ~$1.10. | Time decay and pullback to max pain; IV is not low. |
| Long Puts / Bear Put Spread | Moderate-Weak | Buy $28/$27 put spread 4/10 (10 DTE) for ~$0.40 debit. | Strong bullish flow and pinning make sustained downside difficult. |
| Iron Condor | Strong | $27/$26P x $29/$30C 4/17 (17 DTE). | Earnings vol spike in early May; break of EM bounds. |
| Calendar/Diagonal | Moderate | **Reverse Calendar:** Sell $30C 5/08 (33.2% IV), Buy $30C 5/15 (29.1% IV) for a net credit. | Spot moves far from $30, killing theta decay; pin risk. |
| PMCC / LEAPS Diagonal | Moderate-Strong | Buy $25C 12/18 (262 DTE, ~$4.50), Sell $30C 5/15 (45 DTE) against it. | Capital intensive; long-dated IV decay if thesis fails. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for PFE for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.